Merit Medical Systems, Inc. designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management. The company also offers cardiovascular and critical care products comprising infection prevention and safety, and fluid management and monitoring devices. In addition, it provides interventional oncology and spine products, such as vertebral compression fractures; tumor ablation systems; inflation syringes; microspheres for treating hypervascularized tumors and liver cancer; polyvinyl alcohol particles to treat hypervascularized tumors; and microcatheters for the controlled and selective infusion of diagnostic, embolic, or therapeutic agents into vessels. Further, the company offers endoscopy products, such as non-vascular stents, esophageal stents, biliary stent systems, esophageal balloon dilators, inflation devices, and guide wires; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical systems sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:MMSI
CUSIP58988910
Phone801-253-1600
Debt
Debt-to-Equity Ratio0.53
Current Ratio2.76
Quick Ratio1.42
Price-To-Earnings
Trailing P/E Ratio43.59
Forward P/E Ratio34.02
P/E Growth2.64
Sales & Book Value
Annual Sales$727.85 million
Price / Sales3.86
Cash Flow$2.3524 per share
Price / Cash23.72
Book Value$13.47 per share
Price / Book4.14
Profitability
EPS (Most Recent Fiscal Year)$1.28
Net Income$27.52 million
Net Margins2.37%
Return on Equity10.01%
Return on Assets6.01%
Miscellaneous
Employees4,876
Outstanding Shares50,410,000
Market Cap$2,820.63
Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions
What is Merit Medical Systems' stock symbol?
Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."
How were Merit Medical Systems' earnings last quarter?
Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its quarterly earnings results on Wednesday, April, 25th. The medical instruments supplier reported $0.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.29 by $0.02. The medical instruments supplier had revenue of $203.04 million for the quarter, compared to analyst estimates of $192.60 million. Merit Medical Systems had a return on equity of 10.01% and a net margin of 2.37%. The firm's revenue was up 18.7% on a year-over-year basis. During the same period last year, the company earned $0.28 EPS. View Merit Medical Systems' Earnings History.
When is Merit Medical Systems' next earnings date?
What price target have analysts set for MMSI?
10 brokers have issued 12-month price objectives for Merit Medical Systems' shares. Their predictions range from $44.00 to $62.00. On average, they expect Merit Medical Systems' share price to reach $52.3333 in the next year. This suggests that the stock has a possible downside of 6.2%. View Analyst Ratings for Merit Medical Systems.
What is the consensus analysts' recommendation for Merit Medical Systems?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
Who are some of Merit Medical Systems' key competitors?
Some companies that are related to Merit Medical Systems include DexCom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Haemonetics (HAE), Globus Medical (GMED), Penumbra (PEN), Cantel Medical (CMD), Novocure (NVCR), NuVasive (NUVA), Irhythm Technologies (IRTC), Nevro (NVRO), Mazor Robotics (MZOR), Luminex (LMNX) and Glaukos (GKOS).
Who are Merit Medical Systems' key executives?
Merit Medical Systems' management team includes the folowing people:
- Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 68)
- Mr. Ronald A. Frost, Chief Operating Officer (Age 56)
- Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 57)
- Mr. Joseph C. Wright, Pres of International Division (Age 48)
- Mr. Raul Parra, Interim Chief Financial Officer
Has Merit Medical Systems been receiving favorable news coverage?
Headlines about MMSI stock have trended somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Merit Medical Systems earned a news impact score of 0.12 on Accern's scale. They also gave media stories about the medical instruments supplier an impact score of 45.84 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
Who are Merit Medical Systems' major shareholders?
Merit Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Copper Rock Capital Partners LLC (0.84%), American Capital Management Inc. (0.55%), Fisher Asset Management LLC (0.28%), Bank of Montreal Can (0.09%), Municipal Employees Retirement System of Michigan (0.03%) and Amalgamated Bank (0.02%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras and Richard W Edelman. View Institutional Ownership Trends for Merit Medical Systems.
Which institutional investors are selling Merit Medical Systems stock?
MMSI stock was sold by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Fisher Asset Management LLC, Municipal Employees Retirement System of Michigan and American Capital Management Inc.. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower and Richard W Edelman. View Insider Buying and Selling for Merit Medical Systems.
Which institutional investors are buying Merit Medical Systems stock?
How do I buy shares of Merit Medical Systems?
Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Merit Medical Systems' stock price today?
One share of MMSI stock can currently be purchased for approximately $55.80.
How big of a company is Merit Medical Systems?
Merit Medical Systems has a market capitalization of $2.82 billion and generates $727.85 million in revenue each year. The medical instruments supplier earns $27.52 million in net income (profit) each year or $1.28 on an earnings per share basis. Merit Medical Systems employs 4,876 workers across the globe.
How can I contact Merit Medical Systems?
Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]
MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
